GDUFA Research Outcomes
Oligonucleotide APIs
This section contains scientific publications, presentations, and posters arising from GDUFA-funded research relevant to complex active pharmaceutical ingredients that are oligonucleotides, including antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs), and associated impurities in generic products.
-
Introduction to complex products and FDA considerations
Jiang, Jeff
-
Oligonucleotides: Current Thinking and Analytical Challenges Identified in the Nusinersen PSG Development
Zhang, Deyi
-
Developing Product-Specific Guidances on Oligonucleotides for Generic Drug Development
Zhang, Deyi
-
Considerations for Abbreviated New Drug Application of Generic Peptide Drug Products
Zhang, Deyi
-
Evaluation of Quantitative Capsule Rupture Test Methods and Data Variability in Generic Omega-3 Capsule Applications
Liu, Hao; Suh, Min Sung; Kozak, Darby; Pang, Eric
-
Scientific Considerations for Synthetic Peptides Referencing Peptide Drugs of rDNA Origin
Hu, Ping; Zhang, Deyi; Kozak, Darby; Jiang, Xiaohui